期刊文献+

辛伐他汀抑制肺癌的作用及机制研究 被引量:3

The anti-proliferation effect of Simvastatin on the lung cancer in vitro
原文传递
导出
摘要 目的观察辛伐他汀对肺癌A549细胞的作用,并探讨可能的作用机制。方法用不同浓度辛伐他汀处理A549细胞,采用MTT法检测其对A549细胞的生长抑制情况;用瑞士吉姆萨染色观察辛伐他汀对A549细胞形态学的影响;流式细胞仪检测活性氧(Reactive oxygen species,ROS)的浓度;实时荧光定量PCR测定miR-21、Rho A和K-Ras mRNA的表达。结果辛伐他汀对A549细胞的IC50=23μmol·L-1;形态学观察其能促进A549细胞凋亡且促使细胞内ROS明显升高;miR-21、Rho A和K-Ras mRNA的表达上调。结论辛伐他汀有一定的体外抑制A549细胞的效应;可能是通过改变细胞内的氧化应激水平来发挥的抗肿瘤效应。 OBJECTIVE To investigate the inhibitory effect and the anti - tumor mechanism of Simvastatin on A549 cell line in vitro. METHODS MTT assay was used to assess the inhibitory effects of Simvastatin on proliferatin of A549 cell line. Wright Giemsa staining was used to observe the effects of Simvastatin on A549 cell line. Flow cytometry was employed to measure ROS level. Real - time quantitative PCR was employed to analyze the mRNA expression levels of miR - 21, RhoA and K - Ras. RESULTS IC50 of Simv- astatin to A549 ceils was 23 μm. Evident apoptosis phenomenons in A549 cell line were observed after treated with different concentra- tions of Simvastatin in Wright Giemsa. ROS level increased obviously in Simvastatin - treated cells, miR -21, RhoA and K - Ras mRNA were up - regulated in Simvastatin - treated cells. CONCLUSION Simvastatin has the inhibitory effect of inhibition towarding A549 cell line, which might be caused by the changes of intracellular redox state.
出处 《华西药学杂志》 CAS CSCD 2016年第6期566-568,共3页 West China Journal of Pharmaceutical Sciences
基金 教育部国家基础科学人才培养能力提高项目基金 大学生创新创业训练计划资助(编号:J1103604)
关键词 辛伐他汀 肺癌 凋亡 活性氧 作用机制 Simvastatin Lung cancer Apoptosis Reactive oxygen species Anti - proliferation effect
  • 相关文献

参考文献3

二级参考文献34

  • 1张彦玲,杨汉煜,赵曦.LC-MS/MS测定人血浆中的辛伐他汀[J].华西药学杂志,2008,23(3):337-339. 被引量:7
  • 2张红,徐文炜,胡晓,李艳艳,熊玉卿.人血浆中辛伐他汀的HPLC-MS/MS测定[J].中国医药工业杂志,2006,37(12):833-835. 被引量:15
  • 3江波,袁虹,许东航,周权,阮邹荣.液相色谱-电喷雾串联质谱法测定人血浆中辛伐他汀浓度[J].药物分析杂志,2007,27(6):800-804. 被引量:7
  • 4Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S, et al. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2002;106: 143-60.
  • 5Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I,Corey D, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003;23: 434-9.
  • 6Rajapurohitam V, Gan XT, Kirshenbaum LA, Karmazyn M. The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res 2003;93: 277-9.
  • 7Xu FP, Chen MS, Wang YZ, Yi Q, Lin SB, Chen AF, et al. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 2004;110: 1269-75.
  • 8Wallace AM, McMahon AD, Packard C J, Kelly A, Shepherd J,Gaw A, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).Circulation 2001;104: 3052-6.
  • 9Paolisso G, Tagliamonte MR, Galderisi M, Zito GA, Petrocelli A,Carella C, et al. Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. Hypertension 1999;34: 1047-52.
  • 10Luo JD, Chen AF. Perspectives on the cardioprotective effects of statins. Curr Med Chem 2003;10: 1593-601.

共引文献14

同被引文献15

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部